Reversal of fibrosis and portal hypertension by Empagliflozin treatment of CCl4-induced liver fibrosis: Emphasis on gal-1/NRP-1/TGF-β and gal-1/NRP-1/VEGFR2 pathways
Ashraf A. Noah, Nesrine S. El-Mezayen, Samar O. El-Ganainy, Inas E. Darwish, Elham A. Afify
Topics & Concepts
Hepatic stellate cellEndocrinologyEmpagliflozinInternal medicineHepatic fibrosisMedicineFibrosisCancer researchEnosSignal transductionVascular endothelial growth factorChemistryNitric oxideDiabetes mellitusType 2 diabetesNitric oxide synthaseBiochemistryVEGF receptorsLiver physiology and pathologyApelin-related biomedical researchPancreatic and Hepatic Oncology Research